AAAAAA

   
Results: 1-7 |
Results: 7
THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: PATER JL LOFTERS WS ZEE B DEMPSEY E WALDE D MOQUIN JP WILSON K HOSKINS P GUEVIN RM VERMA S NAVARI R KROOK JE HAINSWORTH J PALMER M CHIN C
Citation: Jl. Pater et al., THE ROLE OF THE 5-HT3 ANTAGONISTS ONDANSETRON AND DOLASETRON IN THE CONTROL OF DELAYED-ONSET NAUSEA AND VOMITING IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, Annals of oncology, 8(2), 1997, pp. 181-185
ORAL ONDANSETRON-8-MG TWICE-DAILY IS AS EFFECTIVE AS 8-MG 3 TIMES DAILY IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATELYEMETOGENIC CANCER-CHEMOTHERAPY
Authors: BECK TM YORK M CHANG A NAVARI R HARVEY WH MESHAD M GRIFFIN D WENTZ A
Citation: Tm. Beck et al., ORAL ONDANSETRON-8-MG TWICE-DAILY IS AS EFFECTIVE AS 8-MG 3 TIMES DAILY IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATELYEMETOGENIC CANCER-CHEMOTHERAPY, Cancer investigation, 15(4), 1997, pp. 297-303
PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: LOFTERS WS PATER JL ZEE B DEMPSEY E WALDE D MOQUIN JP WILSON K HOSKINS P GUEVIN RM VERMAN S NAVARI R KROOK JE HAINSWORTH J PALMER M CHIN C
Citation: Ws. Lofters et al., PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 15(8), 1997, pp. 2966-2973
DOUBLE-BLIND, RANDOMIZED COMPARISON OF THE ANTIEMETIC EFFICACY OF INTRAVENOUS DOLASETRON MESYLATE AND INTRAVENOUS ONDANSETRON IN THE PREVENTION OF ACUTE CISPLATIN-INDUCED EMESIS IN PATIENTS WITH CANCER
Authors: HESKETH P NAVARI R GROTE T GRALLA R HAINSWORTH J KRIS M ANTHONY L KHOJASTEH A TAPAZOGLOU E BENEDICT C HAHNE W
Citation: P. Hesketh et al., DOUBLE-BLIND, RANDOMIZED COMPARISON OF THE ANTIEMETIC EFFICACY OF INTRAVENOUS DOLASETRON MESYLATE AND INTRAVENOUS ONDANSETRON IN THE PREVENTION OF ACUTE CISPLATIN-INDUCED EMESIS IN PATIENTS WITH CANCER, Journal of clinical oncology, 14(8), 1996, pp. 2242-2249
FADROZOLE HYDROCHLORIDE IN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CARCINOMA
Authors: MILLER AA LIPTON A HENDERSON IC NAVARI R MULAGHA MT COOPER J
Citation: Aa. Miller et al., FADROZOLE HYDROCHLORIDE IN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CARCINOMA, Cancer, 78(4), 1996, pp. 789-793
COMPARATIVE CLINICAL-TRIAL OF GRANISETRON AND ONDANSETRON IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS
Authors: NAVARI R GANDARA D HESKETH P HALL S MAILLIARD J RITTER H FRIEDMAN C FITTS D
Citation: R. Navari et al., COMPARATIVE CLINICAL-TRIAL OF GRANISETRON AND ONDANSETRON IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS, Journal of clinical oncology, 13(5), 1995, pp. 1242-1248
TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA - DOUBLE-BLIND COMPARISON OF RAPID AND SLOW INTRAVENOUS-INFUSION REGIMENS OF PAMIDRONATE DISODIUM AND SALINE ALONE
Authors: GUCALP R THERIAULT R GILL I MADAJEWICZ S CHAPMAN R NAVARI R AHMANN F ZELENAKAS K HEFFERNAN M KNIGHT RD
Citation: R. Gucalp et al., TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA - DOUBLE-BLIND COMPARISON OF RAPID AND SLOW INTRAVENOUS-INFUSION REGIMENS OF PAMIDRONATE DISODIUM AND SALINE ALONE, Archives of internal medicine, 154(17), 1994, pp. 1935-1944
Risultati: 1-7 |